STUDY

Low-dose Accutane worked at least as well as doxycycline for rosacea bumps

“Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study.” Gollnick H et al. Journal der Deutschen Dermatologischen Gesellschaft. March 2010

Gollnick H et al. · Journal der Deutschen Dermatologischen Gesellschaft · March 2010

Randomized controlled trialRosacea (Breakouts)AccutaneDoxycycline
The finding

In a 12-week trial of 573 people with bumpy rosacea, isotretinoin at 0.3 mg/kg was shown to work at least as well as doxycycline, cutting bumps by 90% versus 83%.

Type of study

Where this study sits on the evidence spectrum

Some kinds of studies are much more reliable than others. Studies further right do more to rule out chance and bias.

Weaker evidenceStronger evidence
Lab or animal studyCase reportCase seriesCohort studyRandomized trialMeta-analysis
Randomized and double-blind. A random process decided who got which treatment, and neither the patients nor the doctors knew which one it was. A placebo group was included.
At a glance

Who was studied and for how long

People
573
Rosacea with bumps and pimples (subtypes II and III)
Length
12 weeks
Isotretinoin, doxycycline, or placebo
Condition
Bumpy to severe rosacea
Tested in 35 German centers
Compared
Isotretinoin vs doxycycline
Three isotretinoin doses plus a placebo
Best dose
0.3 mg/kg
The results shown here
What they did

How the study worked

573 peoplerosacea with bumps and pimplesRANDOMSPLITIsotretinoin0.3 mg/kgOne group12 weeksDoxycyclineOne group12 weeksMEASURED ATWeek 12by doctors573 peoplerosacea with bumps and pimplesRANDOMSPLITIsotretinoin0.3 mg/kgOne group · 12 weeksDoxycyclineOne group · 12 weeksMEASURED ATWeek 12by doctors
1. Split at random573 people with bumpy rosacea were randomly put in groups.
2. Five treatmentsGroups took isotretinoin at 0.1, 0.3, or 0.5 mg per kg, doxycycline, or a placebo for 12 weeks.
3. Compared resultsDoctors counted bumps and rated overall improvement. The study tested whether isotretinoin was at least as good as doxycycline.
What they found

The results

Isotretinoin 0.3 mg/kgDoxycycline

Fewer red bumps and pimples

Average drop in bumps from the start

Isotretinoin
−90%
Doxycycline
−83%

Skin completely clear

Share rated in complete remission by doctors

Isotretinoin
24%
Doxycycline
14%

Marked improvement

Share rated as marked improvement by doctors

Isotretinoin
57%
Doxycycline
55%
The study asked whether isotretinoin was at least as good as doxycycline, not whether it was better, and the answer was yes. Isotretinoin 0.3 mg/kg also beat placebo. The numbers for isotretinoin were higher, but this summary does not show the gap was large enough to call it better.
How much to trust it

Strengths and limits

Strengths

  • Randomized and double-blind
  • Large: 573 people at 35 centers
  • Included both a placebo group and doxycycline as a comparison
  • Tested three isotretinoin doses

Limits

  • Isotretinoin for rosacea is off-label, meaning it is not an approved use
  • Tested only 12 weeks, so it cannot show how long results last
  • Isotretinoin has serious side effects and needs close monitoring
  • Only bumpy and severe rosacea, not flushing alone
High confidence. A large double-blind trial with placebo and doxycycline comparison groups. It shows isotretinoin is a valid option, not a first choice for everyone.
What it means for you

The takeaway

Valid option

For bumpy, moderate to severe rosacea, low-dose isotretinoin worked about as well as doxycycline in this trial. It is an option when antibiotics are not suitable or do not work.

Isotretinoin carries serious risks, including birth defects. It needs a prescription and close follow-up. This is a conversation to have with your dermatologist.

Pages that cite this study

Read more on Dermapedia

Condition
Rosacea (Breakouts)
Medication
Accutane
Medication
Doxycycline
Compare
Accutane vs Doxycycline
Terms in this study

Words worth knowing

Subtype II and III rosacea

Rosacea with red bumps and pimples (II) or thickened skin and severe bumps (III).

Non-inferior

Shown to work at least as well as the comparison, within an agreed margin. It does not mean better.

Complete remission

The doctor rated the rosacea as fully cleared.

Off-label

Used for a condition the medicine is not officially approved for.

Original source

Gollnick H, Blume-Peytavi U, Szabó EL, Meyer KG, Hauptmann P, Popp G, Sebastian M, Zwingers T, Willers C, von der Weth R. Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges. 2010;8(7):505–515.

PMID 20337772